Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.
Etienne G, Dulucq S, Bauduer F, Adiko D, Lifermann F, Dagada C, Lenoir C, Schmitt A, Klein E, Madene S, Fort MP, Bijou F, Moldovan M, Turcq B, Robbesyn F, Durrieu F, Versmée L, Katsahian S, Faberes C, Lascaux A, Mahon FX. Etienne G, et al. Among authors: moldovan m. Cancers (Basel). 2020 Sep 4;12(9):2521. doi: 10.3390/cancers12092521. Cancers (Basel). 2020. PMID: 32899879 Free PMC article.
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.
Etienne G, Faberes C, Bauduer F, Adiko D, Lifermann F, Dagada C, Lenoir C, Schmitt A, Klein E, Fort MP, Bijou F, Turcq B, Robbesyn F, Durrieu F, Versmée L, Madene S, Moldovan M, Katsahian S, Charles-Nelson A, Lascaux A, Mahon FX, Dulucq S. Etienne G, et al. Among authors: moldovan m. Cancer Med. 2021 Jun;10(11):3635-3645. doi: 10.1002/cam4.3921. Epub 2021 May 14. Cancer Med. 2021. PMID: 33988316 Free PMC article.
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.
Dartigeas C, Quinquenel A, Ysebaert L, Dilhuydy MS, Anglaret B, Slama B, Le Du K, Tardy S, Tchernonog E, Orfeuvre H, Voillat L, Guidez S, Malfuson JV, Dupuis S, Deslandes M, Feugier P, Leblond V; FIRE Investigators Group. Dartigeas C, et al. Ann Hematol. 2024 Mar 6. doi: 10.1007/s00277-024-05666-3. Online ahead of print. Ann Hematol. 2024. PMID: 38443660
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells.
Warda W, Larosa F, Neto Da Rocha M, Trad R, Deconinck E, Fajloun Z, Faure C, Caillot D, Moldovan M, Valmary-Degano S, Biichle S, Daguindau E, Garnache-Ottou F, Tabruyn S, Adotevi O, Deschamps M, Ferrand C. Warda W, et al. Among authors: moldovan m. Cancer Res. 2019 Feb 1;79(3):663-675. doi: 10.1158/0008-5472.CAN-18-1078. Epub 2018 Dec 4. Cancer Res. 2019. PMID: 30514753
Healing of Skin Wounds in Rats Using Creams Based on Symphytum Officinale Extract.
Mârza SM, Dăescu AM, Purdoiu RC, Dragomir M, Tătaru M, Melega I, Nagy AL, Gal A, Tăbăran F, Bogdan S, Moldovan M, Pall E, Munteanu C, Magyari K, Papuc I. Mârza SM, et al. Among authors: moldovan m. Int J Mol Sci. 2024 Mar 7;25(6):3099. doi: 10.3390/ijms25063099. Int J Mol Sci. 2024. PMID: 38542069 Free PMC article.
Developing Bioactive Hydrogels with Peptides for Dental Application.
Muntean A, Sarosi C, Petean I, Cuc S, Carpa R, Chis IA, Ilea A, Delean AG, Moldovan M. Muntean A, et al. Among authors: moldovan m. Biomedicines. 2024 Mar 21;12(3):694. doi: 10.3390/biomedicines12030694. Biomedicines. 2024. PMID: 38540307 Free PMC article.
335 results